Nifty
Sensex
:
:
24213.30
79476.63
217.95 (0.91%)
694.39 (0.88%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 524602 | NSE: Not Listed

47.07
05-Nov-2024
  • Open
  • High
  • Low
  • Previous Close
  •  47.07
  •  47.07
  •  47.07
  •  48.03
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  695
  •  32713
  •  63.14
  •  28.31

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 56.48
  • 58.04
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 69.14
  • 0.21%
  • 4.63

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.00%
  • 0.18%
  • 23.99%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 0.83%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 47.11
  • 47.11
  • 47.11

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.66
  • 3.66
  • 3.66

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.81
  • 19.81
  • 19.81

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Net Sales
11.37
5.87
93.70%
13.43
10.06
33.50%
9.80
5.40
81.48%
4.82
2.37
103.38%
Expenses
10.83
5.33
103.19%
12.71
9.68
31.30%
8.71
4.65
87.31%
4.35
2.28
90.79%
EBITDA
0.54
0.54
0.00%
0.73
0.37
97.30%
1.08
0.75
44.00%
0.47
0.08
487.50%
EBIDTM
4.75%
9.14%
5.40%
3.70%
11.05%
13.89%
9.78%
3.59%
Other Income
0.00
0.00
0
0.03
0.17
-82.35%
0.00
0.02
-100.00%
0.00
0.00
0
Interest
0.21
0.29
-27.59%
0.32
0.13
146.15%
0.16
0.14
14.29%
0.17
0.10
70.00%
Depreciation
0.15
0.18
-16.67%
0.19
0.10
90.00%
0.18
0.19
-5.26%
0.18
0.24
-25.00%
PBT
0.18
0.07
157.14%
0.25
0.31
-19.35%
0.74
0.43
72.09%
0.12
-0.25
-
Tax
0.00
0.00
0
0.06
0.00
0
0.19
0.00
0
0.05
0.00
0
PAT
0.18
0.07
157.14%
0.19
0.31
-38.71%
0.56
0.43
30.23%
0.07
-0.25
-
PATM
1.56%
1.26%
1.40%
3.10%
5.69%
8.04%
1.45%
-10.73%
EPS
0.15
0.09
66.67%
0.16
0.20
-20.00%
0.46
0.50
-8.00%
0.06
-0.29
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Net Sales
39.42
34.08
18.73
Net Sales Growth
66.33%
81.95%
 
Cost Of Goods Sold
32.14
27.31
15.95
Gross Profit
7.28
6.77
2.78
GP Margin
18.46%
19.87%
14.84%
Total Expenditure
36.60
31.25
17.58
Power & Fuel Cost
-
0.15
0.04
% Of Sales
-
0.44%
0.21%
Employee Cost
-
2.33
0.64
% Of Sales
-
6.84%
3.42%
Manufacturing Exp.
-
0.09
0.05
% Of Sales
-
0.26%
0.27%
General & Admin Exp.
-
1.26
0.82
% Of Sales
-
3.70%
4.38%
Selling & Distn. Exp.
-
0.06
0.05
% Of Sales
-
0.18%
0.27%
Miscellaneous Exp.
-
0.06
0.02
% Of Sales
-
0.18%
0.11%
EBITDA
2.82
2.83
1.15
EBITDA Margin
7.15%
8.30%
6.14%
Other Income
0.03
0.03
0.19
Interest
0.86
0.93
0.43
Depreciation
0.70
0.73
0.59
PBT
1.29
1.20
0.33
Tax
0.30
0.25
0.07
Tax Rate
23.26%
20.83%
21.21%
PAT
1.00
0.52
0.26
PAT before Minority Interest
1.00
0.95
0.26
Minority Interest
0.00
-0.43
0.00
PAT Margin
2.54%
1.53%
1.39%
PAT Growth
78.57%
100.00%
 
EPS
0.83
0.43
0.22

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Shareholder's Funds
12.28
3.08
Share Capital
12.00
3.00
Total Reserves
0.28
0.08
Non-Current Liabilities
5.26
7.69
Secured Loans
1.78
1.97
Unsecured Loans
3.39
5.68
Long Term Provisions
0.00
0.00
Current Liabilities
12.24
7.35
Trade Payables
4.12
0.24
Other Current Liabilities
0.37
0.37
Short Term Borrowings
7.53
6.56
Short Term Provisions
0.22
0.19
Total Liabilities
32.57
20.17
Net Block
4.48
5.03
Gross Block
4.48
5.03
Accumulated Depreciation
0.00
0.00
Non Current Assets
5.98
5.10
Capital Work in Progress
0.00
0.00
Non Current Investment
1.40
0.00
Long Term Loans & Adv.
0.10
0.07
Other Non Current Assets
0.00
0.00
Current Assets
26.56
15.06
Current Investments
0.00
0.00
Inventories
6.47
2.71
Sundry Debtors
14.52
6.62
Cash & Bank
0.04
0.16
Other Current Assets
5.53
1.15
Short Term Loans & Adv.
4.09
4.42
Net Current Assets
14.33
7.71
Total Assets
32.55
20.18

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Cash From Operating Activity
-4.13
-1.10
PBT
1.19
0.33
Adjustment
1.66
1.01
Changes in Working Capital
-6.76
-2.44
Cash after chg. in Working capital
-3.91
-1.10
Interest Paid
0.00
0.00
Tax Paid
-0.22
0.00
Other Direct Exp. Paid
0.00
0.00
Extra & Other Items
0.00
0.00
Cash From Investing Activity
-1.58
-5.30
Net Fixed Assets
0.00
Net Investments
-1.40
Others
-0.18
Cash from Financing Activity
5.59
4.47
Net Cash Inflow / Outflow
-0.11
-1.93
Opening Cash & Equivalents
0.16
2.09
Closing Cash & Equivalent
0.04
0.16

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Book Value (Rs.)
10.22
3.56
ROA
3.59%
1.28%
ROE
12.36%
8.40%
ROCE
10.12%
4.39%
Fixed Asset Turnover
7.16
3.72
Receivable days
113.22
129.01
Inventory Days
49.16
52.83
Payable days
29.10
5.40
Cash Conversion Cycle
133.28
176.44
Total Debt/Equity
1.04
4.63
Interest Cover
2.29
1.75

News Update:


  • Bandaram Pharma Pack - Quarterly Results
    13th Aug 2024, 16:18 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.